Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

A decades-long study reveals that shedding extra weight in midlife, without medication or surgery, could reduce your risk of serious illness and help you live longer. Study: Weight Loss in Midlife, ...

People who reduce excess weight in midlife can roughly halve their risk of developing chronic disease later in life. That’s the conclusion of three long-term studies from the UK and Finland, analyzed ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a study ...

More than 4,700 adults aged 55 to 75 were involved in the six-year study. A large six-year trial found that older adults who combined a Mediterranean diet with regular exercise were far less likely to ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D).

A medical expert weighs in with practical, proven tips to help you achieve and maintain successful weight loss. Losing weight with type 2 diabetes can present unique challenges, but with the right ...

A major study from Tübingen found that prediabetic individuals who normalized their blood sugar through healthy habits — even without shedding pounds — cut their risk of type 2 diabetes by 71%.

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...